JP2024038267A5 - - Google Patents

Download PDF

Info

Publication number
JP2024038267A5
JP2024038267A5 JP2024000646A JP2024000646A JP2024038267A5 JP 2024038267 A5 JP2024038267 A5 JP 2024038267A5 JP 2024000646 A JP2024000646 A JP 2024000646A JP 2024000646 A JP2024000646 A JP 2024000646A JP 2024038267 A5 JP2024038267 A5 JP 2024038267A5
Authority
JP
Japan
Prior art keywords
methyl
alkyl
carboxamide
oxopiperazine
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024000646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024038267A (ja
Filing date
Publication date
Priority claimed from JP2023567928A external-priority patent/JP7522943B2/ja
Application filed filed Critical
Publication of JP2024038267A publication Critical patent/JP2024038267A/ja
Publication of JP2024038267A5 publication Critical patent/JP2024038267A5/ja
Priority to JP2025264265A priority Critical patent/JP2026048891A/ja
Pending legal-status Critical Current

Links

JP2024000646A 2021-05-07 2024-01-05 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類 Pending JP2024038267A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025264265A JP2026048891A (ja) 2021-05-07 2025-12-18 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163185637P 2021-05-07 2021-05-07
US63/185,637 2021-05-07
US202163286691P 2021-12-07 2021-12-07
US63/286,691 2021-12-07
JP2023567928A JP7522943B2 (ja) 2021-05-07 2022-05-05 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023567928A Division JP7522943B2 (ja) 2021-05-07 2022-05-05 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025264265A Division JP2026048891A (ja) 2021-05-07 2025-12-18 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類

Publications (2)

Publication Number Publication Date
JP2024038267A JP2024038267A (ja) 2024-03-19
JP2024038267A5 true JP2024038267A5 (https=) 2024-10-23

Family

ID=81927873

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2023567928A Active JP7522943B2 (ja) 2021-05-07 2022-05-05 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類
JP2024000646A Pending JP2024038267A (ja) 2021-05-07 2024-01-05 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類
JP2025264265A Pending JP2026048891A (ja) 2021-05-07 2025-12-18 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2023567928A Active JP7522943B2 (ja) 2021-05-07 2022-05-05 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025264265A Pending JP2026048891A (ja) 2021-05-07 2025-12-18 Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類

Country Status (21)

Country Link
US (1) US20220380338A1 (https=)
EP (1) EP4334293A1 (https=)
JP (3) JP7522943B2 (https=)
KR (1) KR20240005878A (https=)
CN (1) CN117881664A (https=)
AR (1) AR125786A1 (https=)
AU (1) AU2022270115B2 (https=)
BR (1) BR112023023239A2 (https=)
CA (1) CA3217565A1 (https=)
CL (1) CL2023003295A1 (https=)
CO (1) CO2023015096A2 (https=)
CR (1) CR20230519A (https=)
DO (1) DOP2023000242A (https=)
EC (1) ECSP23083881A (https=)
GE (2) GEAP202416407A (https=)
IL (1) IL308215A (https=)
JO (1) JOP20230284A1 (https=)
MX (1) MX2023013146A (https=)
PE (1) PE20250021A1 (https=)
TW (1) TWI827037B (https=)
WO (1) WO2022235859A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023013147A (es) * 2021-05-07 2023-11-28 Merck Sharp & Dohme Llc Aril 3-oxopiperazin carboxamidas y heteroaril 3-oxopiperazin carboxamidas como inhibidores de nav1.8.
JP2025513452A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物
UY40234A (es) 2022-04-22 2023-11-15 Vertex Pharma Compuestos heteroarilo para el tratamiento del dolor
AU2023257313A1 (en) 2022-04-22 2024-10-31 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
GEAP202516634A (en) 2022-04-22 2025-02-25 Vertex Pharma Heteroaryl compounds for the treatment of pain
AU2023391870A1 (en) 2022-12-06 2025-06-05 Vertex Pharmaceuticals Incorporated Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels
TW202523312A (zh) * 2023-10-16 2025-06-16 美商克洛諾斯生技有限公司 離胺酸乙醯基轉移酶抑制劑
CN117645533B (zh) * 2023-10-20 2024-10-11 泰州精英化成医药科技有限公司 一种4-(三氟甲基)环己酮的合成方法
WO2025090511A1 (en) 2023-10-23 2025-05-01 Vertex Pharmaceuticals Incorporated Methods of preparing modulators of sodium channels and solid forms of the same for treating pain
WO2025090480A1 (en) 2023-10-23 2025-05-01 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
WO2025090465A1 (en) 2023-10-23 2025-05-01 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
WO2025090516A1 (en) 2023-10-23 2025-05-01 Vertex Pharmaceuticals Incorporated Methods of preparing compounds for treating pain and solid forms thereof
CN117567323A (zh) * 2023-10-30 2024-02-20 湖北泰盛化工有限公司 一种(s)-4-氯-2-((甲氧基羰基)氨基)丁酸乙酯的制备方法
WO2025122953A1 (en) 2023-12-07 2025-06-12 Vertex Pharmaceuticals Incorporated Dosing regimens and formulations of suzetrigine for use in the treatment of acute and chronic pain
US20260001877A1 (en) 2024-06-28 2026-01-01 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
WO2026013449A2 (en) 2024-07-11 2026-01-15 Sea4Us - Biotecnologia E Recursos Marinhos, Sa Oxazolidone-derived compounds and their use in the treatment of chronic and acute pain
WO2026030525A1 (en) 2024-07-31 2026-02-05 Vertex Pharmaceuticals Incorporated Zilvetrigine dosage forms and dosing regimens for treating pain

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52122392A (en) * 1976-04-07 1977-10-14 Sangyo Kagaku Kenkyu Kyokai Novel antibacterials
EP1723129A1 (en) * 2003-12-18 2006-11-22 Cv Therapeutics, Inc. 1-akan-2-ol substituted piperazine and piperidine compounds
CN101883760A (zh) 2007-10-11 2010-11-10 沃泰克斯药物股份有限公司 用作电压-门控钠通道抑制剂的杂芳基酰胺类
CA2702101A1 (en) 2007-10-11 2009-04-16 Vertex Pharmaceuticals Incorporated Aryl amides useful as inhibitors of voltage-gated sodium channels
AU2008310661A1 (en) 2007-10-11 2009-04-16 Vertex Pharmaceuticals Incorporated Amides useful as inhibitors of voltage-gated sodium channels
WO2011026240A1 (en) * 2009-09-04 2011-03-10 Zalicus Pharmaceuticals Ltd. Oxopiperazine derivatives for the treatment of pain and epilepsy
US8889863B2 (en) * 2010-07-16 2014-11-18 Vanderbilt University Stereoselective methods, catalysts and intermediates for the synthesis of (−)-Nutlin-3 and related compounds
AU2014212431B2 (en) 2013-01-31 2018-04-05 Vertex Pharmaceuticals Incorporated Amides as modulators of sodium channels
KR102295748B1 (ko) 2013-01-31 2021-09-01 버텍스 파마슈티칼스 인코포레이티드 나트륨 채널의 조절제로서의 피리돈 아미드
CN105073738B (zh) 2013-01-31 2018-01-05 沃泰克斯药物股份有限公司 作为钠通道调节剂的喹啉及喹喔啉酰胺类
ES2654393T3 (es) 2013-07-19 2018-02-13 Vertex Pharmaceuticals Incorporated Sulfonamidas como moduladores de los canales de sodio
LT3080134T (lt) 2013-12-13 2018-11-12 Vertex Pharmaceuticals Incorporated Piridono amidų provaistai, naudotini kaip natrio kanalų moduliatoriai
JP2017114764A (ja) * 2014-04-25 2017-06-29 武田薬品工業株式会社 片頭痛治療剤
WO2015184383A1 (en) * 2014-05-29 2015-12-03 St. Jude Children's Research Hospital Aryl-substituted imidazoles and methods of making and using same
KR101844984B1 (ko) 2016-05-31 2018-04-03 한림대학교 산학협력단 5원 헤테로사이클릭 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US11358977B2 (en) 2017-05-16 2022-06-14 Vertex Pharmaceuticals Incorporated Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
SG11202000230VA (en) 2017-07-11 2020-02-27 Vertex Pharma Carboxamides as modulators of sodium channels
AU2018371216B2 (en) * 2017-11-23 2024-09-19 Oslo University Hospital Hf Treatment of tachycardia
WO2019226931A1 (en) * 2018-05-25 2019-11-28 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
WO2020092187A1 (en) * 2018-11-02 2020-05-07 Merck Sharp & Dohme Corp. 2-amino-n-phenyl-nicotinamides as nav1.8 inhibitors
EP3873893A1 (en) * 2018-11-02 2021-09-08 Merck Sharp & Dohme Corp. 2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors
US20230114728A1 (en) * 2019-11-26 2023-04-13 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
BR112022024476A2 (pt) * 2020-06-17 2022-12-27 Merck Sharp & Dohme Llc 5-oxopirrolidino-3-carboxamidas como inibidores de nav1.8
GEP20257750B (en) * 2020-06-17 2025-03-25 Merck Sharp & Dohme Llc 2-oxoimidazolidine-4-carboxamides as nav1.8 inhibitors

Similar Documents

Publication Publication Date Title
JP2024038267A5 (https=)
IL308215A (en) Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitors
JPWO2021257418A5 (https=)
IL299180A (en) 2-OXOIMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS
FI4094804T3 (fi) Aryyliamidijohdannainen, jolla on kasvaimia estävä vaikutus
RU2011152973A (ru) Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунных и аутоиммунных заболеваний
JP2021515004A5 (https=)
JP2012528178A5 (https=)
JP5667684B2 (ja) 関節炎の治療方法
JP2023123854A5 (https=)
JP2010532386A5 (https=)
RU2015113746A (ru) Замещенные сульфонамиды
JP2019038820A5 (https=)
RU2018106453A (ru) Соединения
JP2014523851A5 (https=)
RU2012127790A (ru) Индуцирующие апоптоз агенты для лечения рака и иммунных и аутоиммунных заболеваний
RU2014110623A (ru) Пирролопиразиновые ингибиторы киназы
RU2018140250A (ru) Пролекарство производного аминокислоты
JP2013531070A5 (https=)
JP2022502362A5 (https=)
RU2015144385A (ru) Ациклические цианоэтилпиразолопиридоны в качестве ингибиторов янус-киназы
RU2015112914A (ru) Бензимидазолы в качестве активных агентов для центральной нервной системы
JP2021511324A5 (https=)
RU2016132858A (ru) Производные фторнафтила
AR060619A1 (es) Triazoloquinazolinonas como inhibidores de las quinasas de punto de control